INCB059872 dihydrochloride is a potent, orally active, selective and irreversible Lysine-Specific Demethylase 1 (LSD1) inhibitor. INCB059872 dihydrochloride can be used for the research of myeloid leukemia.
性状
Solid
IC50 & Target[1][2]
KDM1/LSD1
体外研究(In Vitro)
INCB059872 (25 nM; 48 小时; 293T 细胞) dihydrochloride 增加增强子活性和基因表达。INCB059872 (25 nM; 48 小时; THP-1 细胞) dihydrochloride 使 THP-1 在一个细胞倍增时间内或大约 3 天内显示出生长缺陷。INCB059872 (THP-1 细胞) dihydrochloride 调节 PRO-seq 分析鉴定基因和增强子。 has not independently confirmed the accuracy of these methods. They are for reference only.Western Blot Analysis
体内研究(In Vivo)
INCB059872 (10 mg/kg; p.o.; 0, 4, or 6 天; C57BL/6J 小鼠) dihydrochloride 使单细胞 RNA-seq 显示骨髓祖细胞群。 has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: C57BL/6J mice
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献
[1]. Johnston G, et al. Nascent transcript and single-cell RNA-seq analysis defines the mechanism of action of the LSD1 inhibitor INCB059872 in myeloid leukemia. Gene. 2020;752:144758.
溶解度数据
In Vitro: DMSO : 3.57 mg/mL (7.77 mM; ultrasonic and warming and heat to 60°C)配制储备液